Nuvation Bio annual current ratio
2020
2021
2022
2023
2024
2025
Nuvation Bio Current Ratio Growth & History (NUVB)
Nuvation Bio's current ratio was 6.95 for fiscal 2025.
View full Nuvation Bio company overviewNuvation Bio annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 6.95 | −2.09 | −23.08% |
| 2024 | 2024-12-31 | 9.04 | −35.08 | −79.52% |
| 2023 | 2023-12-31 | 44.11 | −6.59 | −13.00% |
| 2022 | 2022-12-31 | 50.70 | 5.09 | +11.15% |
| 2021 | 2021-12-31 | 45.62 | 11.93 | +35.42% |
| 2020 | 2020-12-31 | 33.69 | — | — |
Nuvation Bio quarterly current ratio
Q2.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 8.37 | −1.02 | −10.84% |
| Q1 2026 | 2026-03-31 | 7.44 | −1.57 | −17.46% |
| Q4 2025 | 2025-12-31 | 6.95 | −2.09 | −23.08% |
| Q3 2025 | 2025-09-30 | 8.48 | −1.09 | −11.43% |
| Q2 2025 | 2025-06-30 | 9.39 | −2.10 | −18.27% |
| Q1 2025 | 2025-03-31 | 9.01 | −29.57 | −76.64% |
| Q4 2024 | 2024-12-31 | 9.04 | −35.08 | −79.52% |
| Q3 2024 | 2024-09-30 | 9.57 | −29.17 | −75.29% |
| Q2 2024 | 2024-06-30 | 11.49 | −36.02 | −75.81% |
| Q1 2024 | 2024-03-31 | 38.58 | −13.42 | −25.80% |
| Q4 2023 | 2023-12-31 | 44.11 | −6.59 | −13.00% |
| Q3 2023 | 2023-09-30 | 38.74 | −9.89 | −20.35% |
| Q2 2023 | 2023-06-30 | 47.51 | 13.93 | +41.50% |
| Q1 2023 | 2023-03-31 | 51.99 | 17.10 | +49.03% |
| Q4 2022 | 2022-12-31 | 50.70 | 5.09 | +11.15% |
| Q3 2022 | 2022-09-30 | 48.63 | −11.23 | −18.76% |
| Q2 2022 | 2022-06-30 | 33.57 | −47.01 | −58.34% |
| Q1 2022 | 2022-03-31 | 34.89 | −48.31 | −58.06% |
| Q4 2021 | 2021-12-31 | 45.62 | 11.93 | +35.42% |
| Q3 2021 | 2021-09-30 | 59.86 | — | — |
| Q2 2021 | 2021-06-30 | 80.58 | 80.56 | +350739.71% |
| Q1 2021 | 2021-03-31 | 83.19 | — | — |
| Q4 2020 | 2020-12-31 | 33.69 | — | — |
| Q2 2020 | 2020-06-30 | 0.02 | — | — |
Nuvation Bio current ratio trends
Over the last five fiscal years, Nuvation Bio's current ratio decreased from 33.69 to 6.95, a change of −26.74. The latest reported quarter, Q2 2026, shows 8.37.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nuvation Bio source filings ↗